Nav: Home

Improvised naloxone nasal sprays lack evidence of absorption and effect

February 04, 2016

Naloxone hydrochloride is a medication that can reverse the effects of an opioid overdose. First responders (peers, family, police, etc.) may prefer nasal sprays to injectable naloxone, which has led to widespread use of improvised naloxone kits with atomisers for nasal delivery of the drug. On 18 November 2015, the US Food and Drug Administration (FDA) approved a nasal naloxone product to replace those improvised kits.

In a debate paper published online today by the scientific journal Addiction, top researchers at the National Addiction Centre at King's College London criticise the extensive use of improvised nasal naloxone kits without testing and without regulatory approval. Improvised nasal naloxone kits were first introduced in the early 2000s in the absence of licensed non-injectable products, and today they continue to be used in the US (where improvised kits are still in circulation in the community) and also in an increasing number of countries where nasal Narcan has not yet been approved.

The authors point out that there isn't enough information available on improvised nasal naloxone kits to warrant this level of acceptance. Improvised nasal kits consist of standard naloxone syringes (developed and licensed for injection), to which a nasal atomizer is attached. The formulation is not concentrated, as naloxone syringes are only commercially available in concentrations of up to 1mg/ml. The single pharmacokinetic study published on non-concentrate naloxone showed that only 4% of naloxone is absorbed when administered nasally. Clinical trials on improvised nasal naloxone kits are underway, but no data on levels of naloxone absorbed have been published.

Lead author Professor John Strang says, "We are attracted to nasal naloxone as a concept, but we are concerned that improvised nasal sprays have been accepted by the treatment field without the sort of testing that would be demanded if a new drug delivery route were proposed for treatment of other populations. We wouldn't accept untested improvised nasal adrenaline/epinephrine for treating emergency allergic reactions. So why are makeshift nasal naloxone kits good enough for people with opioid dependence?"

Strang also points out that we also haven't considered how reliably nasal naloxone works in opioid users whose nasal mucosa may be damaged from drug snorting, or obstructed by vomit during overdose. Ambulance-based studies indicate that between 9 and 26% of opioid overdose victims fail to respond to nasal naloxone. Strang says, "It's one thing to use nasal naloxone in a hospital or from an ambulance, where a doctor or paramedic can administer naloxone by injection if the nasal dose doesn't work. But these nasal naloxone kits, whether FDA-approved or not, are designed to help caregivers save overdose victims on the spot, so they need to be reliable. More data are needed to understand how reliably nasal naloxone reverses opioid overdose in the community. With a naloxone spray now licensed (in the U.S. only) and licensed naloxone injections available internationally, clinicians should either prescribe the long-established injection naloxone or, in the US at least, the newly-approved naloxone nasal spray. They should not prescribe untested, improvised nasal sprays for which absorption remains unknown, probably poor and likely vary variable."


Related Drug Articles:

New cancer drug makes commonly prescribed chemo drug more effective when given together
Researchers have found a way to increase the effectiveness of a widely used cancer drug while decreasing the risk of heart-damaging side effects, according to a new study by researchers from The University of Texas Medical Branch at Galveston and Texas Tech University Health Sciences Center.
BC's drug plan deductibles do not lower drug use for some seniors
Adding a modest 2% income-based deductible for prescription drugs did not appear to deter some seniors from filling prescriptions, found a study of British Columbia's public drug plan published in CMAJ (Canadian Medical Association Journal)
Drug-resistant bacteria in patients' urine or stools raise risk of drug-resistant sepsis
People who have recently been found to have drug-resistant bacteria in their urine or stool samples have a greatly increased risk of developing a bloodstream infection that is also resistant to certain antibiotics, according to a study presented at the 27th European Congress of Clinical Microbiology and Infectious Diseases.
Drug discovery researchers awarded grant to refine malaria drug
A research team from the Virginia Tech Center for Drug Discovery has received a $431,126 two-year grant from the National Institutes of Health to make improved versions of a promising compound called MMV008138, or 8138 for short.
New drug benefits patients with multi-drug resistant HIV
A new monoclonal antibody, ibalizumab appears to benefit patients with multidrug-resistant HIV, according to phase 3 research being presented at IDWeek.
Novel algorithm predicts drug combinations to treat drug resistant fungal infections
Scientists have created an algorithm that can identify drug combinations to treat fungal infections that have become resistant to current drug treatments.
Drug-overdose deaths hold steady in some high drug trafficking areas
Areas in the US with the highest drug-overdose death rates are not always places with high drug trafficking, according to a new University of Pittsburgh Graduate School of Public Health analysis.
Once-a-day epilepsy drug may prevent seizures as well as twice-a-day drug
A new study suggests that an epilepsy drug that can be taken once a day may control seizures as well as a drug that must be taken twice a day, according to a preliminary study released today that will be presented at the American Academy of Neurology's 68th Annual Meeting in Vancouver, Canada, April 15 to 21, 2016.
New hybrid drug plugs the hole in malaria drug resistance
The World Health Organization recommends treating malaria with artemisinin combination therapy (ACT), consisting of artemisinin and another drug.
Compact drug synthesizer could revolutionize drug delivery
Researchers have developed a system the size of a household fridge that can synthesize a variety of pharmaceuticals in short periods of time, including an antihistamine, an antidepressant, a common local anesthetic, and a central nervous system depressant.

Related Drug Reading:

Davis's Drug Guide for Nurses
by April Hazard Vallerand PhD RN FAAN (Author), Cynthia A. Sanoski BS PharmD FCCP BCPS (Author)


Davis’s Drug Guide for Nurses®, Fifteenth Edition delivers all of the information you need to administer medications safely across the lifespan—well-organized monographs for hundreds of generic and thousands of trade-name drugs.



New information on the National Cancer Institute's "Common Terminology Criteria for Adverse Events" classification systemNew appendices: Understanding biosimilar drugsSafe disposal of unused drugs: What patients need to knowPrescription drug abuse: Identifying and treating toxicityPregnancy-Lactation-Reproduction information highlighted in every... View Details

Mosby's 2018 Nursing Drug Reference, 31e (SKIDMORE NURSING DRUG REFERENCE)
by Linda Skidmore-Roth RN MSN NP (Author)

Choose the drug handbook trusted for nearly 30 years! From the leading name in nursing, Mosby’s 2018 Nursing Drug Reference is a full-color portable nursing drug handbook that makes it easy to find the most vital information on the drugs that nurses administer most frequently. More than 5,000 drugs are profiled ― including 20-30 new entries for drugs recently approved by the FDA. . No other drug guide places a higher emphasis on patient safety, with Black Box Warnings for dangerous adverse reactions, Safety Alerts for situations requiring special attention, and a... View Details

Drugs: From Discovery to Approval
by Rick Ng (Author)

The third edition of this best-selling book continues to offer a user-friendly, step-by-step introduction to all the key processes involved in bringing a drug to the market, including the performance of pre-clinical studies, the conduct of human clinical trials, regulatory controls, and even the manufacturing processes for pharmaceutical products. 

Concise and easy to read, Drugs: From Discovery to Approval, Third Edition quickly introduces basic concepts, then moves on to discuss target selection and the drug discovery process for both small and large molecular drugs. The... View Details

NCLEX-RN Drug Guide: 300 Medications You Need to Know for the Exam (Kaplan Test Prep)
by Kaplan Nursing (Author)

Ideal for studying on-the-go, Kaplan's portable, pocket-sized NCLEX-RN Drug Guide provides concise review of the most commonly tested medications on the NCLEX-RN. Flashcard-style pages feature more than 300 frequently tested terms and explanations, including drug family, nursing considerations, side effects, and the purpose of each drug.

Streamlined Review
Flashcard-style pages with more than 300 of the most commonly tested drugs grouped by medication categoryThe most up-to-date content, including new focus on each drug's purposeIndex of brand names and generic... View Details

Little Dental Drug Booklet
by Not Available (Author)

View Details

Drug Information Handbook: A Clinically Relevant Resource for All Healthcare Professionals
by Lexicomp (Author)

Endorsed by the American Pharmacists Association (APhA), the Drug Information Handbook is chosen daily by healthcare professionals as their resource to help improve medication safety and enhance patient care. This handbook follows a dictionary-like format, with drug products organized alphabetically and cross-referenced by U.S. and Canadian brand names and index terms. Clinicians have access to more than 1600 drug monographs, each offering up to 45 fields of information specific to a particular medication. Supplementing the drug information is an extensive Appendix, offering helpful treatment... View Details

Drugs and Society
by Glen R. Hanson (Author), Peter J. Venturelli (Author), Annette E. Fleckenstein (Author)

Each new print copy includes Navigate 2 Advantage Access that unlocks a comprehensive and interactive eBook, student practice activities and assessments, the full Student Study Guide, a full suite of instructor resources, and learning analytics reporting tools.

Revised to keep pace with the latest data and statistics, Drugs and Society, Thirteenth Edition with Navigate 2 Advantage Access, continues to captivate students by taking a multidisciplinary approach to the impact of drug use and abuse on the lives of average individuals. The authors have integrated their expertise in the... View Details

Saunders Nursing Drug Handbook 2018, 1e
by Robert J. Kizior BS RPh (Author), Barbara B. Hodgson RN OCN (Author)

Organized alphabetically by generic drug name, Saunders Nursing Drug Handbook 2018 provides essential information on more than 1,000 generic and 4,000 trade name drugs. This go-to drug reference features Black Box Alerts and comprehensive coverage of IV drug administration, nursing considerations, and fixed combinations ― all in a handy user-friendly format. To promote better patient care, it uniquely guides you through clinical priorities in the practice setting. New drug monographs cover approximately 25 newly approved drugs by the FDA; and thoroughly updated monographs include... View Details

Best Science Podcasts 2018

We have hand picked the best science podcasts for 2018. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Peering Deeper Into Space
The past few years have ushered in an explosion of new discoveries about our universe. This hour, TED speakers explore the implications of these advances — and the lingering mysteries of the cosmos. Guests include theoretical physicist Allan Adams, planetary scientist Sara Seager, and astrophysicists Natasha Hurley-Walker and Jedidah Isler.
Now Playing: Science for the People

#461 Adhesives
This week we're discussing glue from two very different times. We speak with Dr. Jianyu Li about his research into a new type of medical adhesive. And Dr. Geeske Langejans explains her work making and investigating Stone Age and Paleolithic glues.